Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Schranz

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Open Forum Infectious Diseases|July 12, 2021
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant <i>S. pneumoniae</i> in Ambulatory and Hospitalized Adult Patients in the United StatesVikas Gupta, Kalvin C Yu, Jennifer Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2019
Reply to Tang and LaiThomas M File, Steven P Gelone, Jennifer Schranz, et al.
Journal of Comparative Effectiveness Research|December 17, 2019
The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USAVictoria Divino, Jennifer Schranz, Maureen Early, et al.
Allergy and Asthma Proceedings|January 18, 2017
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidaseKarsten Weller, Marcus Maurer, Moshe Fridman, et al.
Current Medical Research and Opinion|October 1, 2019
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort studyVictoria Divino, Jennifer Schranz, Maureen Early, et al.
Vaccine|October 20, 2006
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)Daniel J Isaacman, Mark A Fletcher, Bernard Fritzell, et al.
Open Forum Infectious Diseases|July 4, 2020
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical TrialsThomas P Lodise, Sam Colman, Elizabeth Alexander, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 15, 2015
Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedemaWilliam Lumry, Daniel Soteres, Richard Gower, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjectsJ Gordon Still, Jennifer Schranz, Thorsten P Degenhardt, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Open Forum Infectious Diseases|July 12, 2021
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant <i>S. pneumoniae</i> in Ambulatory and Hospitalized Adult Patients in the United StatesVikas Gupta, Kalvin C Yu, Jennifer Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2019
Reply to Tang and LaiThomas M File, Steven P Gelone, Jennifer Schranz, et al.
Journal of Comparative Effectiveness Research|December 17, 2019
The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USAVictoria Divino, Jennifer Schranz, Maureen Early, et al.
Allergy and Asthma Proceedings|January 18, 2017
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidaseKarsten Weller, Marcus Maurer, Moshe Fridman, et al.
Current Medical Research and Opinion|October 1, 2019
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort studyVictoria Divino, Jennifer Schranz, Maureen Early, et al.
Vaccine|October 20, 2006
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)Daniel J Isaacman, Mark A Fletcher, Bernard Fritzell, et al.
Open Forum Infectious Diseases|July 4, 2020
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical TrialsThomas P Lodise, Sam Colman, Elizabeth Alexander, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 15, 2015
Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedemaWilliam Lumry, Daniel Soteres, Richard Gower, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjectsJ Gordon Still, Jennifer Schranz, Thorsten P Degenhardt, et al.
Pageof 3